Healthcare, which includes numerous businesses that offer patient care, conduct research and development of novel treatments, ...

The Biden Administration released plans for a new rule that would require Medicare and Medicaid to cover anti-obesity ...

The rising popularity of appetite suppressant ‘obesity drugs’ is causing people to eat less when dining out. Is this a threat ...

Few companies garner as much reliable attention as Novo Nordisk ( NVO) does these days. With a bull market coinciding with a ...

Biohaven's pipeline includes Troriluzole for SCA, BHV-2100 for migraines, and Taldefgrobep Alfa for SMA. See why BHVN stock ...

North Carolina stopped covering weight loss drugs such as Ozempic for state employees without diabetes. But it extended ...

A new weight loss drug called MariTide caused 20 percent weight loss in a recent trial, even better than Wegovy or Ozempic.

This summary covers recent developments in the health sector, including studies on thyroid medications and asthma drugs, ...

The CMS estimated that coverage of the weight-loss drugs will cost the federal government about $25 billion for Medicare and ...

Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...

It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.

Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...